Guided Therapeutics (GTHP) Operating Income (2010 - 2025)
Guided Therapeutics recorded quarterly Operating Income of -$710000.0 in Q4 2025, down 46.39% quarter-over-quarter from -$485000.0 in Q3 2025, and down 32.96% year-over-year from -$1.1 million in Q4 2024.
Guided Therapeutics' Operating Income history runs 16 years deep, the most recent figure standing at -$710000.0 for Q4 2025.
- In Q4 2025, Operating Income fell 32.96% year-over-year to -$710000.0; the TTM figure through Dec 2025 stood at -$2.4 million (down 12.47% YoY), while the FY2025 annual figure was -$2.4 million, down 12.52% from the prior year.
- Operating Income came in at -$710000.0 for Q4 2025 at Guided Therapeutics, down from -$485000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$359000.0 in Q1 2024 to a low of -$1.5 million in Q2 2023.
- A 5-year average of -$678750.0 and a median of -$592000.0 in 2021 frame the typical range for Operating Income.
- Across the five-year window, Operating Income slumped 240.08% in 2021 and surged 57.41% in 2024, its largest moves.
- Guided Therapeutics' Operating Income stood at -$435000.0 in 2021, then tumbled by 117.93% to -$948000.0 in 2022, then jumped by 48.84% to -$485000.0 in 2023, then fell by 10.1% to -$534000.0 in 2024, then plunged by 32.96% to -$710000.0 in 2025.
- According to Business Quant data, Operating Income over the past three periods registered -$710000.0, -$485000.0, and -$763000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -710,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -710,000.00 |
| Sep 30, 2025 | -485,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Mar 31, 2025 | -414,000.00 |
| Dec 31, 2024 | -534,000.00 |
| Sep 30, 2024 | -561,000.00 |
| Jun 30, 2024 | -655,000.00 |
| Mar 31, 2024 | -359,000.00 |
| Dec 31, 2023 | -485,000.00 |
| Sep 30, 2023 | -623,000.00 |
| Jun 30, 2023 | -1.51 Mn |
| Mar 31, 2023 | -843,000.00 |
| Dec 31, 2022 | -948,000.00 |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -717,000.00 |
| Mar 31, 2022 | -443,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -487,000.00 |
| Jun 30, 2021 | -561,000.00 |
| Mar 31, 2021 | -823,000.00 |
| Dec 31, 2020 | -288,000.00 |
| Sep 30, 2020 | -153,000.00 |
| Jun 30, 2020 | -369,000.00 |
| Mar 31, 2020 | -242,000.00 |
| Dec 31, 2019 | -165,000.00 |
| Sep 30, 2019 | -188,000.00 |
| Jun 30, 2019 | -327,000.00 |
| Mar 31, 2019 | -257,000.00 |
| Dec 31, 2018 | -449,000.00 |
| Sep 30, 2018 | -234,000.00 |
| Jun 30, 2018 | -491,000.00 |
| Mar 31, 2018 | -376,000.00 |
| Dec 31, 2017 | -731,000.00 |
| Sep 30, 2017 | -1.34 Mn |
| Jun 30, 2017 | -533,000.00 |
| Mar 31, 2017 | -514,000.00 |
| Dec 31, 2016 | -1.11 Mn |
| Sep 30, 2016 | -679,000.00 |
| Jun 30, 2016 | -898,000.00 |
| Mar 31, 2016 | -1.13 Mn |
| Dec 31, 2015 | -1.54 Mn |
| Sep 30, 2015 | -1.84 Mn |
| Jun 30, 2015 | -1.60 Mn |
| Mar 31, 2015 | -1.49 Mn |
| Dec 31, 2014 | -2.15 Mn |
| Sep 30, 2014 | -2.42 Mn |
| Jun 30, 2014 | -2.03 Mn |
| Mar 31, 2014 | -2.08 Mn |
| Dec 31, 2013 | -1.35 Mn |
| Sep 30, 2013 | -1.64 Mn |
| Jun 30, 2013 | -1.74 Mn |
| Mar 31, 2013 | -1.88 Mn |
| Dec 31, 2012 | -1.17 Mn |
| Sep 30, 2012 | -970,000.00 |
| Jun 30, 2012 | -1.15 Mn |
| Mar 31, 2012 | -996,000.00 |
| Dec 31, 2011 | -2.88 Mn |
| Sep 30, 2011 | -2.65 Mn |
| Jun 30, 2011 | -485,000.00 |
| Mar 31, 2011 | -740,000.00 |
| Jun 30, 2010 | -531,000.00 |